GlassScriptPhysician profile
Jillian Crowley
NPI 1992902977
$5,329.15
in general payments reported to CMS, 2019-2025
30 companies · $1,287 in 2025
The $1,287 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $226 · 2022: $1,076 · 2023: $1,295 · 2024: $1,446 · 2025: $1,287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,028.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,027.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $723.33 | 2022-2025 | Cardiomems |
| E.R. Squibb & Sons, L.L.C. | $526.75 | 2022-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $478.73 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $435.41 | 2022-2025 | Farxiga, Wainua |
| Pfizer INC. | $423.19 | 2022-2025 | |
| Amgen INC. | $350.90 | 2022-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $340.78 | 2022-2024 | Watchman Access System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $297.55 | 2022-2025 | Jardiance |
| Actelion Pharmaceuticals US, INC. | $260.95 | 2021-2025 | Uptravi, Opsumit |
| Alnylam Pharmaceuticals INC. | $183.05 | 2022-2025 | Onpattro |
| Medtronic, INC. | $158.95 | 2025 | Symplicity G3 |
| Heartflow, INC. | $130.97 | 2022-2023 | Ffrct |
| Scpharmaceuticals INC. | $121.58 | 2023-2025 | |
| Lexicon Pharmaceuticals, INC. | $96.26 | 2023 | Inpefa |
| Abiomed | $95.33 | 2024 | Impella |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $94.53 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Janssen Scientific Affairs, LLC | $91.58 | 2023 | Xarelto |
| Edwards Lifesciences Corporation | $86.97 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Kiniksa Pharmaceuticals International, Plc | $78.99 | 2024 | Arcalyst |
| Janssen Pharmaceuticals, INC | $73.50 | 2022 | |
| Impulse Dynamics (USA) INC. | $59.94 | 2023-2024 | Optimizer, Optimizer |
| Amarin Pharma, INC. | $38.58 | 2022 | |
| Merck Sharp & Dohme LLC | $36.69 | 2022-2023 | Verquvo |
| Kiniksa Pharmaceuticals, LTD. | $29.51 | 2023 | Arcalyst |
| Esperion Therapeutics, INC. | $25.86 | 2023 | Nexletol |
| Baxter Healthcare | $23.09 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Medicomp INC | $19.13 | 2025 | Telepatch Cardiac Monitor |
| Sanofi-Aventis U.S. LLC | $18.32 | 2023 | |
| Bridgebio Pharma, INC. | $15.81 | 2025 | Attruby |
| Kowa Pharmaceuticals America, INC. | $12.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jillian Crowley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.